MedTech Innovator Unveils 65 Breakthrough Medtech Startups in its 2025 Cohort

We've got exciting news—The Flume Catheter Company is officially part of the 2025 @MedTechInnovator accelerator!
Many thanks to the mentors, investors, and reviewers who believe in our vision.  We are honored to participate and cannot wait to make the most of the opportunity.

LOS ANGELES – JUNE 5, 2025 – MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced the 65 companies selected for its highly competitive 2025 Accelerator Cohort. These companies, representing the top 4% of nearly 1,500 global applicants, will participate in MTI’s flagship four-month program designed to de-risk innovation and accelerate the path to U.S. market success.

The 2025 cohort includes early and mid-stage medical device, diagnostic, and digital health companies that will receive unparalleled mentorship, strategic guidance, and access to MTI’s world-class ecosystem of industry-leading strategic manufacturers, investors, providers, payers, patients, and other industry stakeholders. Participants also join the highest-performing peer network in the sector. MTI alumni have collectively brought over 400 products to market and raised $10 billion in follow-on funding. Companies in this year’s cohort will compete for a share of $800,000 in non-dilutive funding, with winners selected by audience vote at major industry conferences.

“MedTech Innovator’s accelerator is a comprehensive platform for risk mitigation and value creation that helps the world’s most promising medtech startups become investable,” said Paul Grand, CEO and founder. “Over the next four months, our 2025 cohort will work closely with MTI’s extensive network of mentors and partners to advance these innovative technologies toward U.S. market access and public health benefit.”

Following a rigorous evaluation process, MTI and its corporate partners invited 213 companies (15 percent of applicants) to pitch at this year’s MedTech Innovator Road Tour events in Los Angeles, College Park, Md., and Dublin. The 65 selected cohort companies received feedback from 430 subject matter experts and represent 17 U.S. states and 13 countries.

Hear the patient's experience

We are deeply grateful to Dr. Vaughan and his wife, Jackie, for sharing their experience of FLUME catheter in the first of our planned video testimonials. Each is aimed at giving voice to the experience of patients and those around them … and through this to secure the basis to make FLUME catheter more widely available as an option for patients.

Selected to pitch in Dublin at MedTech Innovator

We are delighted that The Flume Catheter Company Inc. has been chosen to participate in the MEDTECH INNOVATOR INTERNATIONAL PITCH EVENT, and CEO Roger Holmes will present in Dublin, Ireland later this month!

MedTech Innovator is one of the largest and highest-performing accelerators of medical technology in the world and a premiere showcase for innovative medical device, digital health and diagnostic companies.

Each year, MedTech Innovator recognizes 50+ best-in-class startups and scale-ups across the medtech industry. Companies selected for this honor receive a slot in the MedTech Innovator Showcase.

Latest FLUME catheter ready to ship!

Our eagerly-awaited market expansion is underway! Product is arriving in our U.S. warehouse, and initial units will be ready to ship in early April.

Much has happened recently at the FLUME Catheter Company! In addition to having FDA 510(k) clearance for both the urethral and suprapubic indications:

  • We've transitioned manufacturing to one of the largest urinary catheter manufacturers in the world.

  • We’ve incorporated patient and clinician feedback into our forthcoming supply of catheters, which now features a 10 ml fill balloon of our innovative design.

  • We are licensed to sell in 49 U.S. states & D.C., with the last state to follow shortly.

  • The FLUME® catheter is covered under Medicare Part B.

  • Our third-party logistics partner is set to ship product, and we are continuing to establish additional distribution channels.

If you are a physician interested in learning more or ordering a special introductory box of catheters, please contact us at info@flumecatheter.com. If you are a patient, ask your urologist if you might be a good candidate for the FLUME catheter.

FLUME catheter successfully raises £1.4m Angel III funding round

The Flume Catheter Company has successfully completed its third Angel funding round, raising £1.4m. This will be used to complete the transfer of productions to a world scale catheter manufacturer and to release the latest version of FLUME catheter to a significant group of U.S. clinicians. It will support the business through to the key milestone of initial commercial sales and the basis for further funding to accelerate growth.

New VP Engineering overseeing strategic manufacturing transfer

Kristian Olsen has joined as VP Engineering. Kristian has worked with us since 2019 as the senior project engineer at Biomerics. He has been instrumental in the development of our current device and all the manufacturing processes. We are delighted that Kristian is coming on board and brings a wealth of experience in balloon catheter development. His first task if to oversee the transfer of current production to a leading global contract catheter manufacturer with whom we have signed a supply agreement. We are excited at the prospect of having the support of their capabilities as we look to scale up high quality and efficient production.

Research Study on Comfort of the New FLUME Catheter to Begin Recruitment

Duke Clinical Research Institute and Penn State College of Medicine Partner to Collect Patient Insight on Innovative FLUME Catheter

The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced the launch of a study to gather real-world data on patient experiences with the new FLUME catheter.

AUA 2023, Chicago, April 28-May 1

We are delighted to be exhibiting in the ‘Emerging Corner’ at AUA, aimed at showcasing new innovations in urology.

Come and meet us at Booth #1029

Learn more about our studies to evaluate FLUME vs Foley on

  • Patient comfort and Quality of Life

  • the incidence and costs of CAUTI and other complications.

Register for samples

The FLUME catheter is 510(k) cleared in the U.S.